The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
13 Mar 20264 min read0 viewsOBSERVATIONAL Trial
GIST (Key Takeaways)
RECRUITING · OBSERVATIONAL · Diabetes Mellitus, Type 2 · Enrollment 240 · Sponsor: University of Athens
Clinical Editorial
ClinicalTrials.gov published a clinical update in Cardiology on 13 Mar 2026. The item focuses on The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination. Open the detail page to review the full original feed content.
Source Reference
Read the full original publication from the source journal or publisher link below.